⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 16, 2024

Supplementary Data from Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer

Xuxu Gou Beom-Jun Kim Meenakshi Anurag Jonathan T. Lei Meggie N. Young Matthew V. Holt Diana Fandino Craig T. Vollert Purba Singh Mohammad A. Alzubi Anna Malovannaya Lacey E. Dobrolecki Michael T. Lewis Shunqiang Li Charles E. Foulds Matthew J. Ellis

View Full Paper

Ask AI

Bookmark

Share

Abstract

The Supplementary Material contains a cover page, 8 Supplementary Figures and their legends.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gou et al. (2024) studied this question.

synapsesocial.com/papers/68e587eeb6db643587523e76 https://doi.org/10.1158/0008-5472.27027611.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data from Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer2024
2Data from Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer2024
3Supplementary Data from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer2024
4Supplementary Data from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer2024
5Supplementary Data from Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer2024